Sunol, CA, United States of America

Harry James Hnatyszyn

USPTO Granted Patents = 3 


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Tucson, AZ (US) (2017)
  • Sunol, CA (US) (2018)

Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Harry James Hnatyszyn in Immunohistochemical Assays

Introduction

Harry James Hnatyszyn, an accomplished inventor based in Sunol, California, has made significant contributions to the field of immunohistochemistry. With three patents to his name, Hnatyszyn has developed innovative methods that enhance the detection of crucial biomarkers in various tumor types.

Latest Patents

Hnatyszyn's latest patents include groundbreaking methods for multiplex multiplex immunohistochemical assays. The first patent focuses on detecting CD3 and CD16 in a single sample of colorectal, head & neck, or lung tumors using primary antibodies derived from the same host species. It also outlines techniques for denaturing and blocking the first primary antibody contacted with the sample. His second patent similarly introduces methods for identifying two different epitopes within the same sample, utilizing the same type of primary antibodies and includes effective strategies for antibody optimization.

Career Highlights

Hnatyszyn is affiliated with Ventana Medical Systems, Inc., a leading company in the development of diagnostic products for pathology. Throughout his career, he has demonstrated a strong commitment to advancing immunohistochemical techniques, thereby influencing diagnostic practices in cancer research and patient care.

Collaborations

In his work, Hnatyszyn collaborates with talented colleagues such as Jacquelyn Smith and Erik Olson. These partnerships have played an essential role in the development and refinement of his patented methodologies, promoting teamwork and innovation within the field.

Conclusion

Harry James Hnatyszyn is a notable inventor whose work in immunohistochemical assays reflects his dedication to enhancing cancer diagnostics. With his innovative approaches and collaborative spirit, he continues to contribute remarkably to scientific advancements that can significantly impact patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…